Tag: NYSE:CBRE
-
Keep An Eye Out: Pre-Market Movers And Recommendations
ANALYST RECOMMENDATIONS: Biogen (NASDAQ:BIIB): RBC Capital maintains its outperform rating and reduces the target price from $357 to $351 Cbre (NYSE:CBRE): Raymond James maintains its strong buy recommendation and reduces the target price from $100 to $95. Csx (NASDAQ:CSX): Barclays maintains its overweight recommendation and reduces the target price from $40 to $38. Diamondback (NASDAQ:FANG):…